Innovation Pharmaceuticals Inc (IPIX)

[oddone33320]

“Given the notable interest from global and specialty pharmaceutical companies that we have received following recent Brilacidin-OM data releases, we continue to carefully assess all of our potential alliance opportunities—toward cementing the best pathway forward....The expedient advancement of Brilacidin-OM into later clinical development is a priority, as is the broader expansion of the complete Brilacidin Franchise.”

What is the impression of this line? Is he suggesting they choose between a deal that covers B-OM or one that covers all of B? Or am I reading too much into this...